{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T09:11:52Z","timestamp":1649063512948},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T00:00:00Z","timestamp":1469750400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s00115-016-0164-3","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T12:45:46Z","timestamp":1469796346000},"page":"887-898","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunneuropathien"],"prefix":"10.1007","volume":"87","author":[{"given":"G.","family":"Stoll","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Reiners","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,29]]},"reference":[{"key":"164_CR1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11892-009-0069-7","volume":"9","author":"R Freeman","year":"2009","unstructured":"Freeman R (2009) Not all neuropathy in diabetes is of diabetic etiology: differential diagnosis of diabetic neuropathy. Curr Diab Rep 9:423\u2013431","journal-title":"Curr. Diab. Rep."},{"key":"164_CR2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1212\/WNL.47.1.10","volume":"47","author":"PJ Dyck","year":"1996","unstructured":"Dyck PJ, Grant IA et\u00a0al (1996) Ten steps in characterizing and diagnosing patients with peripheral neuropathy. Neurology 47:10\u201317","journal-title":"Neurology"},{"key":"164_CR3","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","volume":"366","author":"RA Hughes","year":"2005","unstructured":"Hughes RA, Cornblath DR (2005) Guillain-Barre syndrome. Lancet 366:1653\u20131666","journal-title":"Lancet"},{"key":"164_CR4","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","volume":"7","author":"PA Doorn Van","year":"2008","unstructured":"Van Doorn PA, Ruts L, Jacobs BC (2008) Clinical features, pathogenesis, and treatment of Guillain-Barre syndrome. Lancet Neurol 7:939\u2013950","journal-title":"Lancet Neurol"},{"key":"164_CR5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/brain\/awt285","volume":"137","author":"C Fokke","year":"2014","unstructured":"Fokke C, Berg B van den, Drenthen J et al (2014) Diagnosis of Guillain-Barre syndrome and validation of Brighton criteria. Brain 137:33\u201343","journal-title":"Brain"},{"key":"164_CR6","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1212\/WNL.56.6.758","volume":"56","author":"RD Hadden","year":"2001","unstructured":"Hadden RD, Karch H, Hartung HP et al (2001) Preceding infections, immune factors, and outcome in Guillain-Barre syndrome. Neurology 56:758\u2013765","journal-title":"Neurology"},{"key":"164_CR7","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.410390512","volume":"39","author":"CE Hafer-Macko","year":"1996","unstructured":"Hafer-Macko CE, Sheikh KA, Li CY et al (1996) Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol 39:625\u2013635","journal-title":"Ann. Neurol."},{"issue":"11","key":"164_CR8","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1136\/jnnp-2014-310097","volume":"86","author":"A Uncini","year":"2015","unstructured":"Uncini A, Kuwabara S (2015) Nodopathies of the peripheral nerve: an emerging concept. J Neurol Neurosurg Psychiatr 86(11):1186\u20131195. doi: 10.1136\/jnnp-2014-310097","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"164_CR9","volume-title":"Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie","author":"C Sommer","year":"2012","unstructured":"Sommer C, Hartung HP, Heuss D, Kieseier B, Koeppen S, Steck A, Stoll G, Tackenberg B, Toyka KV, Zimprich F (2012) Therapie akuter und chronischer immunvermittelter Neuropathien und Neuritiden. In: Diener HC, Weimar C (Hrsg) Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie. Thieme, Stuttgart"},{"key":"164_CR10","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1212\/WNL.0b013e3182904fcc","volume":"80","author":"B Berg van den","year":"2013","unstructured":"Berg B van den, Bunschoten C, Doorn PA van et al (2013) Mortality in Guillain-Barre syndrome. Neurology 80:1650\u20131654","journal-title":"Neurology"},{"key":"164_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2009.05.020","volume":"215","author":"N Yuki","year":"2009","unstructured":"Yuki N (2009) Fisher syndrome and Bickerstaff brainstem encephalitis (Fisher-Bickerstaff syndrome). J Neuroimmunol 215:1\u20139","journal-title":"J. Neuroimmunol."},{"key":"164_CR12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1055\/s-2008-1062268","volume":"28","author":"DS Saperstein","year":"2008","unstructured":"Saperstein DS (2008) Chronic acquired demyelinating polyneuropathies. Semin Neurol 28:168\u2013184","journal-title":"Semin Neurol"},{"key":"164_CR13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1212\/WNL.54.1.26","volume":"54","author":"RM Berg-Vos van den","year":"2000","unstructured":"Berg-Vos RM van den, Berg LH van den, Franssen H et al (2000) Multifocal inflammatory demyelinating neuropathy: a distinct clinical entity? Neurology 54:26\u201332","journal-title":"Neurology"},{"key":"164_CR14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/B978-0-444-52902-2.00008-4","volume":"115","author":"G Stoll","year":"2013","unstructured":"Stoll G, Wilder-Smith E, Bendszus M (2013) Imaging of the peripheral nervous system. Handb Clin Neurol 115:137\u2013153","journal-title":"Handb Clin Neurol"},{"key":"164_CR15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/mus.20022","volume":"29","author":"PY Bergh van den","year":"2004","unstructured":"Bergh PY van den, Pieret F (2004) Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 29:565\u2013574","journal-title":"Muscle Nerve"},{"key":"164_CR16","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","volume":"17","author":"PY Bergh van den","year":"2010","unstructured":"Bergh PY van den, Hadden RD, Bouche P et\u00a0al (2010) European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society \u2013 first revision. Eur J Neurol 17:356\u2013363","journal-title":"Eur. J. Neurol."},{"key":"164_CR17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1474-4422(10)70021-1","volume":"9","author":"IN Schaik van","year":"2010","unstructured":"Schaik IN van, Eftimov F, Doorn PA van et al (2010) Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial. Lancet Neurol 9:245\u2013253","journal-title":"Lancet Neurol"},{"key":"164_CR18","doi-asserted-by":"publisher","first-page":"Cd003280","DOI":"10.1002\/14651858.cd003280.pub4","volume":"6","author":"M Mahdi-Rogers","year":"2013","unstructured":"Mahdi-Rogers M, Doorn PA van, Hughes RA (2013) Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev 6:Cd003280 doi: 10.1002\/14651858.cd003280.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"164_CR19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1529-8027.2010.00251.x","volume":"15","author":"K Viala","year":"2010","unstructured":"Viala K, Maisonobe T, Stojkovic T et\u00a0al (2010) A current view of the diagnosis, clinical variants, response to treatment and prognosis of chronic inflammatory demyelinating polyradiculoneuropathy. J\u00a0Peripher Nerv Syst 15:50\u201356","journal-title":"J. Peripher. Nerv. Syst."},{"key":"164_CR20","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1468-1331.2006.01467.x","volume":"13","author":"RD Hadden","year":"2006","unstructured":"Hadden RD, Nobile-Orazio E, Sommer C et al (2006) European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of paraproteinaemic demyelinating neuropathies: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 13:809\u2013818","journal-title":"Eur. J. Neurol."},{"key":"164_CR21","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/jnnp.74.4.485","volume":"74","author":"A Pestronk","year":"2003","unstructured":"Pestronk A, Florence J, Miller T et\u00a0al (2003) Treatment of IgM antibody associated polyneuropathies using rituximab. J\u00a0Neurol Neurosurg Psychiatr 74:485\u2013489","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"164_CR22","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1182\/blood-2004-05-2046","volume":"104","author":"A Dispenzieri","year":"2004","unstructured":"Dispenzieri A, Moreno-Aspitia A, Suarez GA et al (2004) Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature. Blood 104:3400\u20133407","journal-title":"Blood"},{"key":"164_CR23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1529-8027.2010.00290.x","volume":"15","author":"Anonymous","year":"2010","unstructured":"Anonymous (2010) European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society \u2013 first revision. J\u00a0Peripher Nerv Syst 15:295\u2013301","journal-title":"J. Peripher. Nerv. Syst."},{"key":"164_CR24","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1212\/01.wnl.0000234063.51897.20","volume":"67","author":"E Delmont","year":"2006","unstructured":"Delmont E, Azulay JP, Giorgi R et\u00a0al (2006) Multifocal motor neuropathy with and without conduction block: a single entity? Neurology 67:592\u2013596","journal-title":"Neurology"},{"key":"164_CR25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(13)70236-9","volume":"13","author":"KG Gwathmey","year":"2014","unstructured":"Gwathmey KG, Burns TM, Collins MP et\u00a0al (2014) Vasculitic neuropathies. Lancet Neurol 13:67\u201382","journal-title":"Lancet Neurol"},{"key":"164_CR26","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1007\/s00415-015-7813-5","volume":"262","author":"N Uceyler","year":"2015","unstructured":"Uceyler N, Geng A, Reiners K et al (2015) Non-systemic vasculitic neuropathy: single-center follow-up of 60 patients. J Neurol 262:2092\u20132100","journal-title":"J. Neurol."},{"key":"164_CR27","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3389\/fimmu.2015.00184","volume":"6","author":"AW Silva De Souza","year":"2015","unstructured":"Silva De Souza AW (2015) Autoantibodies in systemic vasculitis. Front Immunol 6:184 doi: 10.3389\/fimmu.2015.00184","journal-title":"Front Immunol"},{"key":"164_CR28","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1529-8027.2010.00281.x","volume":"15","author":"MP Collins","year":"2010","unstructured":"Collins MP, Dyck PJ, Gronseth GS et al (2010) Peripheral Nerve Society Guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary. J Peripher Nerv Syst 15:176\u2013184","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"Pt 4","key":"164_CR29","first-page":"1091","volume":"119","author":"L Chia","year":"1996","unstructured":"Chia L, Fernandez A, Lacroix C et\u00a0al (1996) Contribution of nerve biopsy findings to the diagnosis of disabling neuropathy in the elderly. A retrospective review of 100 consecutive patients. Brain 119(Pt 4):1091\u20131098","journal-title":"Brain"},{"issue":"3","key":"164_CR30","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/ard.2008.088096","volume":"68","author":"C Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Guillevin L, Cid MC et\u00a0al (2009) EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 68(3):310\u2013317. doi: 10.1136\/ard.2008.088096","journal-title":"Ann. Rheum. Dis."}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-016-0164-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-016-0164-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-016-0164-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T19:30:30Z","timestamp":1498332630000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-016-0164-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,29]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["164"],"URL":"https:\/\/doi.org\/10.1007\/s00115-016-0164-3","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,29]]}}}